Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 3: Special Issue on Influenza Vaccines, commemorating the 100th anniversary of Pandemic Flu
Submit an article Journal homepage
7,159
Views
12
CrossRef citations to date
0
Altmetric
Review

Adjuvanted influenza vaccines

John S. TregoningMucosal Infection and Immunity group, Section of Virology, Department of Medicine, St Mary's Campus, Imperial College London, UKCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8093-8741View further author information
ORCID Icon,
Ryan F. RussellMucosal Infection and Immunity group, Section of Virology, Department of Medicine, St Mary's Campus, Imperial College London, UKView further author information
&
Ekaterina KinnearMucosal Infection and Immunity group, Section of Virology, Department of Medicine, St Mary's Campus, Imperial College London, UKView further author information
Pages 550-564 | Received 01 Sep 2017, Accepted 02 Dec 2017, Published online: 25 Jan 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Tsai-Teng Tzeng, Kit Man Chai, I-Hua Chen, Ray-Yuan Chang, Jen-Ron Chiang & Shih-Jen Liu. (2023) A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine. Emerging Microbes & Infections 12:2.
Read now
Ozan S. Kumru, Sakshi Bajoria, Kawaljit Kaur, John M. Hickey, Greta Van Slyke, Jennifer Doering, Katherine Berman, Charles Richardson, Hans Lien, Harry Kleanthous, Nicholas J. Mantis, Sangeeta B. Joshi & David B. Volkin. (2023) Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD). Human Vaccines & Immunotherapeutics 19:2.
Read now
Katerina Xekouki, Nefeli Lagopati, Costas Demetzos, Maria Gazouli & Natassa Pippa. (2023) A mini review for lipid-based nanovaccines: from their design to their applications. Journal of Liposome Research 33:3, pages 214-233.
Read now
Nadiyah Alqazlan, Jake Astill, Sugandha Raj & Shayan Sharif. (2022) Strategies for enhancing immunity against avian influenza virus in chickens: a review. Avian Pathology 51:3, pages 211-235.
Read now
Simin Wen, Zhengyu Wu, Shuyi Zhong, Mao Li & Yuelong Shu. (2021) Factors influencing the immunogenicity of influenza vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2706-2718.
Read now
Pouria Mosaddeghi, Farbod Shahabinezhad, Mohammadreza Dorvash, Mojtaba Goodarzi & Manica Negahdaripour. (2021) Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19. Human Vaccines & Immunotherapeutics 17:6, pages 1650-1661.
Read now
Caitlyn Kellogg & Ozlem Equils. (2021) The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization. Human Vaccines & Immunotherapeutics 17:3, pages 638-643.
Read now
Lanhua Zhao, Zhe Zhu, Lei Ma & Yingbo Li. (2020) O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying. International Journal of Nanomedicine 15, pages 2071-2083.
Read now
Orli Even-Or, Shani Avniel-Polak, Yechezkel Barenholz & Gabriel Nussbaum. (2020) The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88. Human Vaccines & Immunotherapeutics 16:12, pages 3146-3154.
Read now
Yong-Chao Chen, Jia-Hao Zhou, Jia-Ming Tian, Bai-Hui Li, Li-Hui Liu & Ke Wei. (2020) Adjuvanted-influenza vaccination in patients infected with HIV: a systematic review and meta-analysis of immunogenicity and safety. Human Vaccines & Immunotherapeutics 16:3, pages 612-622.
Read now
Asim Biswas, Alok K. Chakrabarti & Shanta Dutta. (2020) Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines. International Reviews of Immunology 39:1, pages 21-36.
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.